Concepedia

Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes

Eugene Yu-hin Chan, Hazel Webb, E. Yu, Gian Marco Ghiggeri, Markus J. Kemper, Alison Lap‐tak, Tomohiko Yamamura, Aditi Sinha, Arvind Bagga, Claire Dossier,

Kidney International · 2019 · 118 citations · 32 references

DOI

Concepts

References

32

Notice

Kidney International Supplements · 2012 · 968 citations · Full text

KDIGO Clinical Practice Guideline for Glomerulonephritis

Kai‐Uwe Eckardt, Bertram L. Kasiske · 2012 · 870 citations

, , +11

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

Kazumoto Iijima, Mayumi Sako, Kandai Nozu et al. · The Lancet · 2014 · 443 citations

, , +14

Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome

Piero Ruggenenti, Barbara Ruggiero, Paolo Cravedi et al. · Journal of the American Society of Nephrology · 2014 · 268 citations

, , +16

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy

Kerstin Benz, J�rg D�tsch, Wolfgang Rascher et al. · Pediatric Nephrology · 2004 · 206 citations

, , +11